Agenus Inc (AGEN)
5.14
+0.17
(+3.42%)
USD |
NASDAQ |
Apr 19, 15:26
Agenus Gross Profit (Quarterly): 16.82M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.82M |
September 30, 2023 | -27.43M |
June 30, 2023 | -34.24M |
March 31, 2023 | -36.51M |
December 31, 2022 | -32.59M |
September 30, 2022 | -23.55M |
June 30, 2022 | -26.06M |
March 31, 2022 | -17.04M |
December 31, 2021 | -34.11M |
September 30, 2021 | 209.20M |
June 30, 2021 | -35.44M |
March 31, 2021 | -26.06M |
December 31, 2020 | -5.109M |
September 30, 2020 | -18.21M |
June 30, 2020 | -12.24M |
March 31, 2020 | -21.24M |
December 31, 2019 | -2.333M |
September 30, 2019 | -26.19M |
June 30, 2019 | -29.53M |
March 31, 2019 | 39.76M |
December 31, 2018 | -29.58M |
September 30, 2018 | -17.05M |
June 30, 2018 | -13.38M |
March 31, 2018 | -27.80M |
December 31, 2017 | -23.52M |
Date | Value |
---|---|
September 30, 2017 | -22.43M |
June 30, 2017 | -21.62M |
March 31, 2017 | -5.684M |
December 31, 2016 | -20.41M |
September 30, 2016 | -17.14M |
June 30, 2016 | -15.77M |
March 31, 2016 | -19.08M |
December 31, 2015 | -10.31M |
September 30, 2015 | -11.65M |
June 30, 2015 | -18.40M |
March 31, 2015 | -5.267M |
December 31, 2014 | -5.750M |
September 30, 2014 | -3.721M |
June 30, 2014 | -2.149M |
March 31, 2014 | -3.752M |
December 31, 2013 | -2.856M |
September 30, 2013 | -3.237M |
June 30, 2013 | -2.686M |
March 31, 2013 | -1.718M |
December 31, 2012 | -1.583M |
September 30, 2012 | -1.954M |
June 30, 2012 | -2.413M |
March 31, 2012 | 10.67M |
December 31, 2011 | -10.38M |
September 30, 2011 | 0.6537M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-36.51M
Minimum
Mar 2023
209.20M
Maximum
Sep 2021
-9.572M
Average
-26.06M
Median
Jun 2022
Gross Profit (Quarterly) Benchmarks
Protalix BioTherapeutics Inc | 1.63M |
InfuSystems Holdings Inc | 14.88M |
PAVmed Inc | -0.562M |
Allogene Therapeutics Inc | -- |
Pfizer Inc | 6.686B |